JOSHUA ZARITSKY to Male
This is a "connection" page, showing publications JOSHUA ZARITSKY has written about Male.
Connection Strength
0.322
-
LDL-apheresis-induced remission of focal segmental glomerulosclerosis recurrence in pediatric renal transplant recipients. Pediatr Nephrol. 2019 11; 34(11):2343-2350.
Score: 0.025
-
Poor adherence to early childhood blood pressure measurement guidelines in a large pediatric healthcare system. Pediatr Nephrol. 2019 04; 34(4):697-701.
Score: 0.024
-
Epidemiology of peritonitis following maintenance peritoneal dialysis catheter placement during infancy: a report of the SCOPE collaborative. Pediatr Nephrol. 2018 04; 33(4):713-722.
Score: 0.022
-
A case of Fanconi syndrome due to a deferasirox overdose and a trial of plasmapheresis. J Clin Pharm Ther. 2017 Oct; 42(5):634-637.
Score: 0.022
-
High-resolution, whole-body vascular imaging with ferumoxytol as an alternative to gadolinium agents in a pediatric chronic kidney disease cohort. Pediatr Nephrol. 2015 Mar; 30(3):515-21.
Score: 0.018
-
The accuracy of a continuous volumetric balancing system in pediatric continuous renal replacement therapy. Int J Artif Organs. 2014 Mar; 37(3):215-21.
Score: 0.017
-
A biphasic dialytic strategy for the treatment of neonatal hyperammonemia. Pediatr Nephrol. 2014 Feb; 29(2):315-20.
Score: 0.017
-
Short daily hemodialysis is associated with lower plasma FGF23 levels when compared with conventional hemodialysis. Nephrol Dial Transplant. 2014 Feb; 29(2):437-41.
Score: 0.017
-
The crossroad of RAAS modulation, inflammation, and oxidative stress in dialysis patients: light at the end of the tunnel? J Am Soc Nephrol. 2012 Feb; 23(2):189-91.
Score: 0.015
-
Reduction of serum hepcidin by hemodialysis in pediatric and adult patients. Clin J Am Soc Nephrol. 2010 Jun; 5(6):1010-4.
Score: 0.013
-
Successful treatment of calcific uremic arteriolopathy in a pediatric dialysis patient. Pediatr Nephrol. 2010 Feb; 25(2):357-62.
Score: 0.013
-
Sevelamer carbonate increases serum bicarbonate in pediatric dialysis patients. Pediatr Nephrol. 2010 Feb; 25(2):373-5.
Score: 0.013
-
Hepcidin--a potential novel biomarker for iron status in chronic kidney disease. Clin J Am Soc Nephrol. 2009 Jun; 4(6):1051-6.
Score: 0.012
-
Novel genetic testing model: A collaboration between genetic counselors and nephrology. Am J Med Genet A. 2021 04; 185(4):1142-1150.
Score: 0.007
-
Digenic Heterozygous Mutations in SLC34A3 and SLC34A1 Cause Dominant Hypophosphatemic Rickets with Hypercalciuria. J Clin Endocrinol Metab. 2020 07 01; 105(7).
Score: 0.007
-
Global Variation of Nutritional Status in Children Undergoing Chronic Peritoneal Dialysis: A Longitudinal Study of the International Pediatric Peritoneal Dialysis Network. Sci Rep. 2019 03 20; 9(1):4886.
Score: 0.006
-
Adrenocorticotropic Hormone for Childhood Nephrotic Syndrome: The ATLANTIS Randomized Trial. Clin J Am Soc Nephrol. 2018 12 07; 13(12):1859-1865.
Score: 0.006
-
Pharmacokinetics of ferric pyrophosphate citrate administered via dialysate and intravenously to pediatric patients on chronic hemodialysis. Pediatr Nephrol. 2018 11; 33(11):2151-2159.
Score: 0.006
-
Contrast-enhanced magnetic resonance venography in pediatric patients with chronic kidney disease: initial experience with ferumoxytol. Pediatr Radiol. 2016 Aug; 46(9):1332-40.
Score: 0.005
-
Recessive nephrocerebellar syndrome on the Galloway-Mowat syndrome spectrum is caused by homozygous protein-truncating mutations of WDR73. Brain. 2015 Aug; 138(Pt 8):2173-90.
Score: 0.005
-
The use of renal replacement therapy in critically ill pediatric small bowel transplantation candidates and recipients: Experience from one center. Pediatr Transplant. 2015 Jun; 19(4):E88-92.
Score: 0.005
-
Antibacterial responses by peritoneal macrophages are enhanced following vitamin D supplementation. PLoS One. 2014; 9(12):e116530.
Score: 0.005
-
Suppression of iron-regulatory hepcidin by vitamin D. J Am Soc Nephrol. 2014 Mar; 25(3):564-72.
Score: 0.004
-
Correlates of parathyroid hormone concentration in hemodialysis patients. Nephrol Dial Transplant. 2013 Jun; 28(6):1516-25.
Score: 0.004
-
Risk factors for morbidity and mortality in pediatric patients with peritoneal dialysis catheters. J Pediatr Surg. 2013 Jan; 48(1):197-202.
Score: 0.004
-
Association of malnutrition-inflammation complex and responsiveness to erythropoiesis-stimulating agents in long-term hemodialysis patients. Nephrol Dial Transplant. 2013 Jul; 28(7):1936-45.
Score: 0.004
-
Administered paricalcitol dose and survival in hemodialysis patients: a marginal structural model analysis. Pharmacoepidemiol Drug Saf. 2012 Nov; 21(11):1232-9.
Score: 0.004
-
Ventriculoperitoneal shunts in children on peritoneal dialysis: a survey of the International Pediatric Peritoneal Dialysis Network. Pediatr Nephrol. 2013 Feb; 28(2):315-9.
Score: 0.004
-
Hemoglobin level and survival in hemodialysis patients with polycystic kidney disease and the role of administered erythropoietin. Am J Hematol. 2012 Aug; 87(8):833-6.
Score: 0.004
-
Mortality associated with dose response of erythropoiesis-stimulating agents in hemodialysis versus peritoneal dialysis patients. Am J Nephrol. 2012; 35(2):198-208.
Score: 0.004
-
Mineral and bone disorders and survival in hemodialysis patients with and without polycystic kidney disease. Nephrol Dial Transplant. 2012 Jul; 27(7):2899-907.
Score: 0.004
-
Early skeletal and biochemical alterations in pediatric chronic kidney disease. Clin J Am Soc Nephrol. 2012 Jan; 7(1):146-52.
Score: 0.004
-
Defining left ventricular hypertrophy in children on peritoneal dialysis. Clin J Am Soc Nephrol. 2011 Aug; 6(8):1934-43.
Score: 0.004